🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.

Several experts said the demand for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, risking penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and banned associated hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at residence.

After minutes of joining one group, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Within these groups, posts display dark colored parcels with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service said it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has already seen patients injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly significant medical dangers”.